{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:52:00Z","timestamp":1760784720867},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-019-0556-7","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T09:47:37Z","timestamp":1567244857000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pioglitazone suppresses excessive follicular development in murine preantral follicles"],"prefix":"10.1186","volume":"12","author":[{"given":"Sachiko","family":"Nagao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshika","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Honnma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Kiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,31]]},"reference":[{"key":"556_CR1","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR2","first-page":"377","volume-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Boston: Blackwell Scientific Publications; 1992. p. 377\u201384."},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0889-8545(05)70191-1","volume":"28","author":"MJ Iuorno","year":"2001","unstructured":"Iuorno MJ, Nestler JE. Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin N Am. 2001;28:153\u201364.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","volume":"72","author":"V De Leo","year":"1999","unstructured":"De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 1999;72:282\u20135.","journal-title":"Fertil Steril"},{"key":"556_CR5","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83:2001\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"556_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1043-2760(98)00019-8","volume":"9","author":"DH Abbott","year":"1998","unstructured":"Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab. 1998;9(2):62\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"556_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0015-0282(01)02947-8","volume":"77","author":"JR Eisner","year":"2002","unstructured":"Eisner JR, Barnett MA, Dumesic DA, Abbott DH. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril. 2002;77(1):167\u201372.","journal-title":"Fertil Steril"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.fertnstert.2009.02.029","volume":"94","author":"CH Kim","year":"2010","unstructured":"Kim CH, Jeon GH, Kim SR, Kim SH, Chae HD, Kang BM. Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome. Fertil Steril. 2010;94:236\u201341.","journal-title":"Fertil Steril"},{"key":"556_CR9","first-page":"CD003053","volume":"5","author":"T Tang","year":"2012","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;5:CD003053.","journal-title":"Cochrane Database Syst Rev"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0015-0282(01)02843-6","volume":"76","author":"NA Cataldo","year":"2001","unstructured":"Cataldo NA, Abbasi F, McLaughlin TL, Lamendola C, Reaven GM. Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Fertil Steril. 2001;76:1057\u20139.","journal-title":"Fertil Steril"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","volume":"75","author":"DT Vandermolen","year":"2001","unstructured":"Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;75:310\u20135.","journal-title":"Fertil Steril"},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551\u201366.","journal-title":"N Engl J Med"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.clinthera.2006.03.004","volume":"28","author":"P Alivanis","year":"2006","unstructured":"Alivanis P, Giannikouris I, Paliuras C, Arvanitis A, Volanaki M, Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006;28:396\u2013400.","journal-title":"Clin Ther"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2004-1965","volume":"90","author":"C Ortega-Gonzalez","year":"2005","unstructured":"Ortega-Gonzalez C, Luna S, Hernandez L, Crespo G, Aguayo P, Arteaga-Troncoso G, Parra A. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1360\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-019-0505-5","volume":"12","author":"Y Fujibe","year":"2019","unstructured":"Fujibe Y, Baba T, Nagao S, Adachi S, Ikeda K, Morishita M, Kuno Y, Suzuki M, Mizuuchi M, Honnma H, Endo T, Saito T. Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice. J Ovarian Res. 2019;12:31.","journal-title":"J Ovarian Res"},{"key":"556_CR16","first-page":"134","volume":"158","author":"K Hardy","year":"2017","unstructured":"Hardy K, Fenwick M, Mora J, Laird M, Thomson K, Franks S. Onset and heterogeneity of responsiveness to FSH in mouse preantral follicles in culture. Endocrinology. 2017;158:134\u201347.","journal-title":"Endocrinology"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1530\/jrf.0.0820393","volume":"82","author":"DM Halpin","year":"1988","unstructured":"Halpin DM, Charlton HM. Effects of short-term injection of gonadotrophins on ovarian follicle development in hypogonadal (hpg) mice. J Reprod Fertil. 1988;82:393\u2013400.","journal-title":"J Reprod Fertil"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1530\/jrf.0.0170555","volume":"17","author":"T Pedersen","year":"1968","unstructured":"Pedersen T, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil. 1968;17:555\u20137.","journal-title":"J Reprod Fertil"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.biomaterials.2005.06.016","volume":"27","author":"PK Kreeger","year":"2006","unstructured":"Kreeger PK, Deck JW, Woodruff TK, Shea LD. The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials. 2006;27:714\u201323.","journal-title":"Biomaterials"},{"issue":"1","key":"556_CR20","doi-asserted-by":"publisher","first-page":"e12669","DOI":"10.1111\/aji.12669","volume":"78","author":"Kaori Yamada-Nomoto","year":"2017","unstructured":"Yamada-Nomoto K, Yoshino O, Akiyama I, Iwase A, Ono Y, Nakamura T, Harada M, Nakashima A, Shima T, Ushijima A, Osuga Y, Chang RJ, Shimasaki S, Saito S. PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-\u03b2 and TNF-\u03b1 in mononuclear cells by insulin-sensitizing drugs. Am J Reprod Immunol. 2017;78.","journal-title":"American Journal of Reproductive Immunology"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.domaniend.2012.10.002","volume":"44","author":"S Selvaraju","year":"2013","unstructured":"Selvaraju S, Folger JK, Gupta PS, Ireland JJ, Smith GW. Stage-specific expression and effect of bone morphogenetic protein 2 on bovine granulosa cell estradiol production: regulation by cocaine and amphetamine regulated transcript. Domest Anim Endocrinol. 2013;44:115\u201320.","journal-title":"Domest Anim Endocrinol"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/molehr\/gat065","volume":"19","author":"M Lebbe","year":"2013","unstructured":"Lebbe M, Woodruff TK. Involvement of androgens in ovarian health and disease. Mol Hum Reprod. 2013;19:828\u201337.","journal-title":"Mol Hum Reprod"},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/JOE-18-0005","volume":"237","author":"MW Pankhurst","year":"2018","unstructured":"Pankhurst MW, Kelley RL, Sanders RL, Woodcock SR, Oorschot DE, Batchelor NJ. Anti-M\u00fcllerian hormone overexpression restricts preantral ovarian follicle survival. J Endocrinol. 2018;237:153\u201363.","journal-title":"J Endocrinol"},{"key":"556_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7827-10-32","volume":"10","author":"K Fiedler","year":"2012","unstructured":"Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32.","journal-title":"Reprod Biol Endocrinol"},{"key":"556_CR25","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.fertnstert.2009.02.059","volume":"93","author":"DK Shah","year":"2010","unstructured":"Shah DK, Menon KM, Cabrera LM, Vahratian A, Kavoussi SK, Lebovic DI. Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro. Fertil Steril. 2010;93:2042\u20137.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0556-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:08:29Z","timestamp":1598742509000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0556-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0556-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,31]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mice were handled according to the guidelines provided by Sapporo Medical University and the Scientists Center for Animal Welfare. The Institutional Animal Care and Use Committee approved protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}